Plus Therapeutics, Inc. announced the appointment of five leading experts in the fields of neurological surgery and neuro-oncology to its Clinical Advisory Board (CAB). The CAB will advise the Company as it advances its nanoscale radiotherapeutics to treat rare brain and neurological cancers. New members of Plus’ CAB include: Manish Aghi, Nicholas Butowski, Russell Lonser, Alireza Mohammadi and Michael Vogelbaum.